Use of the angiotensin I antagonist, SQ 20881, for lateralizing renal venous renin activity.
D000293:Adolescent; D000328:Adult; D000450:Aldosterone / Q000378:metabolism; D000803:Angiotensin I / Q000037:antagonists & inhibitors*; D000809:Angiotensins / Q000037:antagonists & inhibitors*; D001769:Blood; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000494:pharmacology*; D012082:Renal Veins; D012083:Renin / Q000097:blood / Q000502:physiology*; D013722:Teprotide / Q000494:pharmacology*
D000809:Angiotensins; D009842:Oligopeptides; D000450:Aldosterone; D000803:Angiotensin I; D013722:Teprotide; D012083:Renin